Andrew Arnold

26.0k citations
236 papers · 21.8k · 8 hit papers · h-index 75

Impact in

  • Nephrology top 0.05%
    • Parathyroid Disorders and Treatments
  • Oncology top 0.1%
    • Cancer-related Molecular Pathways
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Research Studies

Papers in

    • Parathyroid Disorders and Treatments 75
    • Cancer-related Molecular Pathways 34
    • Pancreatic and Hepatic Oncology Research 33

Andrew Arnold

231 papers receiving 20.5k citations

Andrew Arnold's Hit Papers

Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions 1995 · 742 citations
7420+14+28Years since publication2505007501000

Peers

Andrew Arnold
Comparison fields: 5 of 177
  • Nephrology 3.9k
  • Oncology 10.2k
  • Cancer Research 2.1k
  • Pathology and Forensic Medicine 2.5k
  • Genetics 1.4k
Replace Dontscho Kerjaschki with:
Dontscho Kerjaschki Austria
Eric G. Neilson United States
Robert S. Weinstein United States
Michelle Petri United States
David L. Lacey United States
Paola Romagnani Italy
David Alan Isenberg United Kingdom
Anthony Jake Demetris United States
Lorraine A. Fitzpatrick United States
Douglas B. Evans United States
Andrew Arnold relative to Dontscho Kerjaschki Austria Dontscho Kerjaschki's profile →
Citations per field
00.5×1.6×
Dontscho Kerjaschki · 1×
Citations per year

Countries citing papers authored by Andrew Arnold

Since Specialization
Citations

This map shows the geographic impact of Andrew Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Arnold more than expected).

Fields of papers citing papers by Andrew Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Arnold. The network helps show where Andrew Arnold may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Arnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Arnold Line = papers co-authored together Andrew Arnold links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 236 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A novel cyclin encoded by a bcl1-linked candidate oncogene
Hit paper breakdown →
19911136
2
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hit paper breakdown →
1992902
3
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Hit paper breakdown →
1994867
4
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Hit paper breakdown →
1995742
5 2001709
6
Physical interaction of the retinoblastoma protein with human D cyclins
Hit paper breakdown →
1993671
7
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
Hit paper breakdown →
1988592
8 1993582
9
Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid Neoplasms
Hit paper breakdown →
1983547
10
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.
Hit paper breakdown →
1983531
11 1998489
12 2003483
13 1994421
14 1988366
15 2005346
16 1995341
17
D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
1991336
18 1999317
19 1990314
20 1989308

About Andrew Arnold

Andrew Arnold is a scholar working on Nephrology, Oncology, Genetics, Pathology and Forensic Medicine and Genetics, having authored 236 papers that have together received 21.8k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (75 papers), Genetic Syndromes and Imprinting (43 papers), Cancer-related Molecular Pathways (34 papers), Pancreatic and Hepatic Oncology Research (33 papers), Neuroendocrine Tumor Research Advances (19 papers), Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Metabolism, Diabetes, and Cancer (14 papers). The work is most often cited by research in Nephrology (3.9k citations), Oncology (10.2k citations), Cancer Research (2.1k citations), Pathology and Forensic Medicine (2.5k citations) and Genetics (1.4k citations). Andrew Arnold has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Robert A. Weinberg, Philip W. Hinds, Randall D. Gaz, Toru Motokura, Steven I. Reed, Lawrence R. Zukerberg, Steven F. Dowdy, Henry M. Kronenberg, Alexandros Papanikolaou and Richard G. Pestell. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Oncology, New England Journal of Medicine, Journal of Clinical Investigation and Journal of Bone and Mineral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact